Century Therapeutics (IPSC) Interest Coverage Ratio (2020 - 2023)
Century Therapeutics (IPSC) reported Interest Coverage Ratio of 257.92 for Q2 2023, down 171.49% year-over-year from 360.8 in Q2 2022, and down 179.78% quarter-over-quarter from 92.19 in Q1 2023.
Century Therapeutics (IPSC) Interest Coverage Ratio (2020 - 2023) Analysis & Trends
Century Therapeutics (IPSC) has 4 years of Interest Coverage Ratio data on file, last reported at 257.92 in Q2 2023.
- Interest Coverage Ratio for Q2 2023 came in at 257.92, down 171.49% year-over-year; the trailing twelve-month figure through Mar 2024 was 1071.87 (down 1249.05% YoY), and the FY2023 annual result was 271.38, down 189.97% from the prior year.
- Interest Coverage Ratio declined to 257.92 in Q2 2023 per IPSC's latest filing, from 92.19 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 45.41 in Q4 2020 and troughed at 291.8 in Q3 2020.
- A 4-year average of 113.15 and a median of 89.67 in 2021 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2021 and 2023: Interest Coverage Ratio soared 72.51% in 2021, then tumbled 171.49% in 2023.
- A 4-year view of Interest Coverage Ratio shows it stood at 45.41 in 2020, then slumped by 91.9% to 87.14 in 2021, then soared by 40.56% to 51.8 in 2022, then plunged by 397.93% to 257.92 in 2023.
- Business Quant data shows IPSC's Interest Coverage Ratio at 257.92 in Q2 2023, 92.19 in Q1 2023, and 51.8 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Century Therapeutics | 444.99 Mn | 444.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -257.92 |
| Mar 31, 2023 | -92.19 |
| Dec 31, 2022 | -51.80 |
| Sep 30, 2022 | -107.22 |
| Jun 30, 2022 | -95.00 |
| Mar 31, 2022 | -119.22 |
| Dec 31, 2021 | -87.14 |
| Sep 30, 2021 | -80.21 |
| Jun 30, 2021 | -72.39 |
| Mar 31, 2021 | -57.52 |
| Dec 31, 2020 | -45.41 |
| Sep 30, 2020 | -291.80 |